Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

The Telomeric Protein TRF2 Is Critical for the Protection of A549 Cells from Both Telomere Erosion and DNA Double-Strand Breaks Driven by Salvicine

Yong-Wei Zhang, Zhi-Xiang Zhang, Ze-Hong Miao and Jian Ding
Molecular Pharmacology March 2008, 73 (3) 824-832; DOI: https://doi.org/10.1124/mol.107.039081
Yong-Wei Zhang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhi-Xiang Zhang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ze-Hong Miao
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jian Ding
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

vol. 73 no. 3 824-832
DOI 
https://doi.org/10.1124/mol.107.039081
PubMed 
18025071

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received June 15, 2007
  • Accepted November 19, 2007
  • Published online February 21, 2008.

Article Versions

  • Earlier version (November 19, 2007 - 07:27).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Yong-Wei Zhang,
  2. Zhi-Xiang Zhang,
  3. Ze-Hong Miao and
  4. Jian Ding
  1. Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People's Republic of China
  1. Address correspondence to:
    Dr. Jian Ding, Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, People's Republic of China. E-mail: jding{at}mail.shcnc.ac.cn
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: November 2007 to July 2022

AbstractFullPdf
Nov 200713092
Dec 200715074
Jan 20087055
Feb 2008251040
Mar 2008433325
Apr 2008672122
May 200827216
Jun 2008492613
Jul 2008441120
Aug 2008391813
Sep 2008721714
Oct 2008441414
Nov 200841816
Dec 200822910
Jan 2009241512
Feb 2009371412
Mar 2009244029
Apr 200993116
May 2009112723
Jun 200983519
Jul 20091528131
Aug 2009143619
Sep 2009142327
Oct 2009193320
Nov 2009251721
Dec 2009241313
Jan 2010331474
Feb 2010282827
Mar 2010163844
Apr 2010283316
May 2010115327
Jun 2010164323
Jul 2010172515
Aug 2010143516
Sep 201083213
Oct 2010152921
Nov 201081812
Dec 2010162915
Jan 201171832
Feb 201123289
Mar 2011122126
Apr 201163923
May 201172025
Jun 201192711
Jul 2011132817
Aug 2011113012
Sep 2011182611
Oct 2011164921
Nov 2011203516
Dec 2011164121
Jan 2012224120
Feb 2012233922
Mar 2012173822
Apr 2012193627
May 2012242521
Jun 2012152623
Jul 2012234216
Aug 2012182020
Sep 2012132717
Oct 2012153313
Nov 2012163223
Dec 201292713
Jan 2013345416
Feb 20139479
Mar 201383112
Apr 2013224120
May 2013203319
Jun 20137145
Jul 20133219
Aug 20139229
Sep 2013151214
Oct 201312305
Nov 201314238
Dec 2013133820
Jan 201418259
Feb 2014102626
Mar 20148287
Apr 201484926
May 201497446
Jun 2014107150
Jul 201492610
Aug 201485432
Sep 2014145254
Oct 2014103124
Nov 201453731
Dec 201452411
Jan 201572821
Feb 201572110
Mar 2015163313
Apr 2015144418
May 2015133019
Jun 2015132510
Jul 2015172620
Aug 2015143118
Sep 20157249
Oct 201541911
Nov 201542917
Dec 201551512
Jan 2016222326
Feb 201672919
Mar 2016101532
Apr 20168109
May 201671410
Jun 201691622
Jul 2016132130
Aug 2016111923
Sep 201662127
Oct 201683422
Nov 2016101510
Dec 201601222
Jan 201723222
Feb 20170279
Mar 201703410
Apr 201712411
May 201752310
Jun 201742611
Jul 201722533
Aug 201742812
Sep 201721511
Oct 20171181
Nov 20173255
Dec 20173207
Jan 20189213
Feb 20181245
Mar 201801818
Apr 20180276
May 20182177
Jun 20183273
Jul 2018186
Aug 2018061
Sep 20180107
Oct 2018096
Nov 20180132
Dec 20181124
Jan 20192014
Feb 2019734
Mar 20192102
Apr 20191403
May 20191221
Jun 2019906
Jul 20191105
Aug 20192201
Sep 2019413
Oct 20191115
Nov 20191905
Dec 20191701
Jan 20201100
Feb 20201011
Mar 20203400
Apr 2020742
May 2020320
Jun 20201200
Jul 20201311
Aug 20201406
Sep 2020811
Oct 20201502
Nov 20201107
Dec 20201613
Jan 20211137
Feb 20211913
Mar 20212212
Apr 2021913
May 20212334
Jun 20213213
Jul 20212318
Aug 20211828
Sep 20211223
Oct 20212104
Nov 20211412
Dec 20212125
Jan 20223524
Feb 2022811
Mar 20221722
Apr 2022732
May 2022916
Jun 20222011
Jul 2022100

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 73 (3)
Molecular Pharmacology
Vol. 73, Issue 3
1 Mar 2008
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Telomeric Protein TRF2 Is Critical for the Protection of A549 Cells from Both Telomere Erosion and DNA Double-Strand Breaks Driven by Salvicine
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

The Telomeric Protein TRF2 Is Critical for the Protection of A549 Cells from Both Telomere Erosion and DNA Double-Strand Breaks Driven by Salvicine

Yong-Wei Zhang, Zhi-Xiang Zhang, Ze-Hong Miao and Jian Ding
Molecular Pharmacology March 1, 2008, 73 (3) 824-832; DOI: https://doi.org/10.1124/mol.107.039081

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

The Telomeric Protein TRF2 Is Critical for the Protection of A549 Cells from Both Telomere Erosion and DNA Double-Strand Breaks Driven by Salvicine

Yong-Wei Zhang, Zhi-Xiang Zhang, Ze-Hong Miao and Jian Ding
Molecular Pharmacology March 1, 2008, 73 (3) 824-832; DOI: https://doi.org/10.1124/mol.107.039081
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Human mAb 3F1 targeting the fuctional epitopes of Siglec-15
  • The regulation and mechanisms of ImKTX58 on KV1.3 channel
  • EIPA, HMA and SMN2 gene regulation
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics